5.80
Lifemd Inc stock is traded at $5.80, with a volume of 1.50M.
It is down -1.53% in the last 24 hours and down -15.08% over the past month.
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
See More
Previous Close:
$5.89
Open:
$5.85
24h Volume:
1.50M
Relative Volume:
0.81
Market Cap:
$275.02M
Revenue:
$193.06M
Net Income/Loss:
$-22.51M
P/E Ratio:
-9.0625
EPS:
-0.64
Net Cash Flow:
$10.63M
1W Performance:
-4.29%
1M Performance:
-15.08%
6M Performance:
+0.52%
1Y Performance:
+10.90%
Lifemd Inc Stock (LFMD) Company Profile
Name
Lifemd Inc
Sector
Industry
Phone
(866) 351-5907
Address
236 FIFTH AVENUE, NEW YORK
Compare LFMD with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
LFMD
Lifemd Inc
|
5.80 | 282.13M | 193.06M | -22.51M | 10.63M | -0.64 |
![]()
VEEV
Veeva Systems Inc
|
276.43 | 45.01B | 2.97B | 809.93M | 1.33B | 4.87 |
![]()
TEM
Tempus Ai Inc
|
86.38 | 13.58B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
71.03 | 12.92B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
92.49 | 7.88B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
37.36 | 7.06B | 906.14M | -52.62M | 89.62M | -0.3621 |
Lifemd Inc Stock (LFMD) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jun-18-25 | Reiterated | BTIG Research | Buy |
Dec-10-24 | Initiated | Lake Street | Buy |
Dec-04-24 | Initiated | Mizuho | Neutral |
Aug-23-24 | Resumed | B. Riley Securities | Buy |
Jun-05-24 | Initiated | KeyBanc Capital Markets | Overweight |
Nov-30-23 | Initiated | Craig Hallum | Buy |
Jul-21-23 | Initiated | Cantor Fitzgerald | Overweight |
Jul-03-23 | Initiated | H.C. Wainwright | Buy |
Mar-10-22 | Initiated | Colliers Securities | Buy |
Oct-04-21 | Resumed | B. Riley Securities | Buy |
View All
Lifemd Inc Stock (LFMD) Latest News
Investors SueWallSt Over LifeMD, Inc. Stock DropContact Levi & Korsinsky to Join - ACCESS Newswire
LifeMD: chief acquisition officer Alvarez sells $443k in shares - Investing.com
ROSEN, THE FIRST FILING FIRM, Encourages LifeMD, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – LFMD - GlobeNewswire Inc.
Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements – Hagens Berman - GlobeNewswire
LifeMD, Inc. Shareholders Who Lost Money on Their - GlobeNewswire
Shareholders that lost money on LifeMD, Inc.(LFMD) should contact Levi & Korsinsky about pending Class ActionLFMD - PR Newswire
Faruqi & Faruqi Reminds LifeMD Investors of the Pending - GlobeNewswire
Shareholders that lost money on LifeMD, Inc. (LFMD) Urged - GlobeNewswire
LifeMD, Inc. (LFMD) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit - MarketScreener
Investors who lost money on LifeMD, Inc.(LFMD) should contact The Gross Law Firm about pending Class ActionLFMD - PR Newswire
Bragar Eagel & Squire, P.C. Reminds Investors of Unicycive, - GlobeNewswire
LifeMD (NASDAQ:LFMD) and Cannlabs (OTCMKTS:CANL) Critical Analysis - Defense World
Lost Money on LifeMD, Inc. (LFMD)? Contact Levi & Korsinsky Before October 25, 2025 to Join Class Action - ACCESS Newswire
Shareholders of LifeMD, Inc. Should Contact The Gross Law - GlobeNewswire
Faruqi & Faruqi Reminds LifeMD Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 27, 2025LFMD - Newsfile
Important Notice to Long-Term Shareholders of Applied - GlobeNewswire
Deadline Alert: LifeMD, Inc. (LFMD) Investors Who Lost - GlobeNewswire
Lawsuit Targets Telehealth Firm LifeMD (LFMD) Over Alleged Misleading Statements -- Hagens Berman - PR Newswire
Shareholders of LifeMD, Inc. (LFMD): Protect Your Rights Before October 25, 2025Contact Levi & Korsinsky - ACCESS Newswire
Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD - MarketScreener
LifeMD stock remains Cantor Fitzgerald’s top 2025 pick with clear growth path - Investing.com
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD - Business Wire
Shareholders that lost money on LifeMD, Inc.(LFMD) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - PR Newswire
Shareholders of LifeMD, Inc. with Significant Financial - GlobeNewswire
ROSEN, THE FIRST FILING FIRM, Encourages LifeMD, Inc. - GlobeNewswire
LifeMD, Inc. (LFMD) Hit With Securities Class Action After - GlobeNewswire
Class Action Alert: Levi & Korsinsky Reminds LifeMD, Inc. (LFMD) Investors of October 25, 2025 Deadline - Newsfile
Shareholders who lost money in shares of LifeMD, Inc. (NASDAQ: LFMD) Should Contact Wolf Haldenstein Immediately - GlobeNewswire
Levi & Korsinsky Reminds LifeMD, Inc. Investors of the - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in LifeMD, Inc. of Class Action Lawsuit and Upcoming DeadlinesLFMD - PR Newswire
Lawsuit filed for Investors who lost money with shares of LifeMD, Inc. (NASDAQ: LFMD) - openPR.com
LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
LIFEMD, INC. (NASDAQ: LFMD) SHAREHOLDER ALERT Bernstein - GlobeNewswire
Lost Money on LifeMD, Inc.(LFMD)? Join Class Action Suit Seeking RecoveryContact The Gross Law Firm - PR Newswire
Silicon Valley - FinancialContent
Faruqi & Faruqi Reminds Biohaven Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 12, 2025 - GlobeNewswire Inc.
Lost Money on LifeMD, Inc. (LFMD)? Join Class Action Before October 25, 2025Contact Levi & Korsinsky - ACCESS Newswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages LifeMD, Inc. - GlobeNewswire
LFMD Investors Have Opportunity to Lead LifeMD, Inc. Securities Fraud Lawsuit First Filed by The Rosen Law Firm - PR Newswire
LifeMD: Navigating the Legal Storm and Stock Volatility Amid Revised Guidance - AInvest
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of LifeMD - MarketScreener
How to contact the Daily Bulletin - FinancialContent
Shareholders SueWallSt in New Class Action Against LifeMD, Inc.Act Now - Nasdaq
Deadline Alert: LifeMD, Inc. (LFMD) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - MarketScreener
Kaplan Fox Encourages Investors of LifeMD, Inc. (LFMD) to Contact the Firm Before Lead Plaintiff Deadline on October 27, 2025 | FinancialContent - FinancialContent
Regression analysis insights on LifeMD Inc. performance2025 Stock Rankings & Daily Entry Point Trade Alerts - Newser
Building trade automation scripts for LifeMD Inc.Layoff News & Free Technical Confirmation Trade Alerts - Newser
October 25, 2025 Deadline: Join Class Action Lawsuit Against LifeMD, Inc. (LFMD) – Contact Levi & Korsinsky - ACCESS Newswire
Levi & Korsinsky Urges LifeMD, Inc. (LFMD) Shareholders to Act Before Lead Plaintiff Deadline October 25, 2025 - ACCESS Newswire
Kaplan Fox Alerts Investors of LifeMD, Inc. (LFMD) to a Securities Class Action Deadline on October 27, 2025 - FinancialContent
Deadline Approaching: LifeMD, Inc. (LFMD) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith - Business Wire
Lifemd Inc Stock (LFMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):